The Directorate of Revenue Intelligence (DRI), Mumbai zonal unit, has conducted searches at pharmaceutical company Cipla’s office in Vikhroli and its depot in Bhiwandi, Thane, over the classification or exemption of an imported finished pharmaceutical product. The searches were conducted on Monday under Section 105 of the Customs Act, 1962.In a regulatory filing under Regulation 30 of the SEBI Listing Regulations, Cipla said the proceedings were related to the classification or exemption of the imported pharmaceutical product. The company confirmed that it had extended full cooperation and assistance to the authorities during the searches.Cipla said the proceedings would have no material impact on its financials, operations or other activities. The filing did not provide further details about the product or the specific classification issue under examination.Cipla shares were trading at ₹1,390.70 on the BSE, down 0.24 per cent. Published - November 17, 2026 11:26 pm IST
DRI searches Cipla’s Mumbai office and Bhiwandi depot over imported drug classification
Full Article
Original Source
Read the full article at Thehindu →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.